• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种由多层肝细胞单层组成的混合生物人工肝。

A hybrid bioartificial liver composed of multiplated hepatocyte monolayers.

作者信息

Uchino J, Tsuburaya T, Kumagai F, Hase T, Hamada T, Komai T, Funatsu A, Hashimura E, Nakamura K, Kon T

机构信息

First Department of Surgery, Hokkaido University School of Medicine, Tokushima University, Sapporo, Japan.

出版信息

ASAIO Trans. 1988 Oct-Dec;34(4):972-7.

PMID:3219260
Abstract

Monolayer cultures of hepatocytes were shown to have good function when compared with suspended cells. The authors manufactured a new hybrid artificial liver containing hepatocyte monolayers and evaluated its function. Hepatocytes isolated from an adult dog liver were cultured on collagen coated borosilicated glass (10 X 20 X 0.04 cm). A long-stroke artificial liver module was constructed by stacking 200 glass plates bearing hepatocytes, which were viable and functioned well during 4 weeks in perfusion culture; glyconeogenesis = 110 ng/micrograms DNA/min, urea synthesis = 3.6 ng/micrograms DNA/min and albumin synthesis = 29 micrograms/10(6) cells/day at the 5th day of perfusion. The levels were maintained for 2 weeks. The new device was applied to anhepatic dogs (Group 3) and compared with untreated (Group 1) and plasma exchange dogs (Group 2). The survival times were 21.3 +/- 5.6 hours in Group 1 (N = 6), 27.8 +/- 4.0 hours in Group 2 (N = 3), and 55.0 +/- 10.3 hours in Group 3 (N = 4). The longest survival was 65 hours. Serum ammonia increased to over 2,000 micrograms/dl after 12 hours in Groups 1 and 2, but remained under 400 micrograms/dl in Group 3. This new type of hybrid system may be a pilot design for the complete artificial liver.

摘要

与悬浮细胞相比,单层培养的肝细胞显示出良好的功能。作者制造了一种包含肝细胞单层的新型混合人工肝,并评估了其功能。从成年犬肝脏分离的肝细胞在胶原包被的硼硅酸盐玻璃(10×20×0.04厘米)上培养。通过堆叠200块带有肝细胞的玻璃板构建了一个长冲程人工肝模块,这些肝细胞在灌注培养的4周内保持存活且功能良好;在灌注第5天时,糖原异生为110纳克/微克DNA/分钟,尿素合成量为3.6纳克/微克DNA/分钟,白蛋白合成量为29微克/10⁶细胞/天。这些水平维持了2周。将该新装置应用于无肝犬(第3组),并与未治疗的犬(第1组)和进行血浆置换的犬(第2组)进行比较。第1组(N = 6)的存活时间为21.3±5.6小时,第2组(N = 3)为27.8±4.0小时,第3组(N = 4)为55.0±10.3小时。最长存活时间为65小时。第1组和第2组在12小时后血清氨升至超过2000微克/分升,但第3组保持在400微克/分升以下。这种新型混合系统可能是全人工肝的初步设计。

相似文献

1
A hybrid bioartificial liver composed of multiplated hepatocyte monolayers.一种由多层肝细胞单层组成的混合生物人工肝。
ASAIO Trans. 1988 Oct-Dec;34(4):972-7.
2
[A hybrid artificial liver system composed of primary cultured canine hepatocytes].
Nihon Geka Gakkai Zasshi. 1990 Feb;91(2):214-22.
3
[Hybrid bioartificial liver using canine hepatocytes in primary culture].[使用原代培养犬肝细胞的混合生物人工肝]
Nihon Geka Gakkai Zasshi. 1989 Apr;90(4):546-55.
4
Development of a bioartificial liver with sandwiched-cultured hepatocytes between two collagen gel layers.一种在两层胶原凝胶层之间夹有培养肝细胞的生物人工肝的研制。
Artif Organs. 1996 Feb;20(2):178-85. doi: 10.1111/j.1525-1594.1996.tb00724.x.
5
Does a porcine hepatocyte hybrid artificial liver prolong the survival time of anhepatic rabbits?猪肝细胞混合型人工肝能延长无肝家兔的生存时间吗?
ASAIO J. 1992 Jul-Sep;38(3):M468-72. doi: 10.1097/00002480-199207000-00078.
6
Extracorporeal application of a gel-entrapment, bioartificial liver: demonstration of drug metabolism and other biochemical functions.凝胶包封生物人工肝的体外应用:药物代谢及其他生化功能的验证
Cell Transplant. 1993 Nov-Dec;2(6):441-52. doi: 10.1177/096368979300200602.
7
Function of culturing monolayer hepatocytes by collagen gel coating and coculture with nonparenchymal cells.通过胶原凝胶包被和与非实质细胞共培养来培养单层肝细胞的功能。
Artif Organs. 1996 Feb;20(2):186-92. doi: 10.1111/j.1525-1594.1996.tb00725.x.
8
Porcine hepatocytes from slaughterhouse organs. An unlimited resource for bioartificial liver devices.来自屠宰场器官的猪肝细胞。生物人工肝装置的无限资源。
ASAIO J. 1995 Apr-Jun;41(2):189-93.
9
Bio-artificial liver from cultured human foetal hepatocytes: feasibility and prospects.源自培养人胎肝细胞的生物人工肝:可行性与前景
Trop Gastroenterol. 2000 Jan-Mar;21(1):22-7.
10
The use of vitrification to preserve primary rat hepatocyte monolayer on collagen-coated poly(ethylene-terephthalate) surfaces for a hybrid liver support system.使用玻璃化法在胶原包被的聚对苯二甲酸乙二酯表面保存原代大鼠肝细胞单层,用于构建混合肝脏支持系统。
Biomaterials. 2009 Sep;30(25):4136-42. doi: 10.1016/j.biomaterials.2009.04.037. Epub 2009 May 28.

引用本文的文献

1
Domino Hepatocyte Transplantation: A Therapeutic Alternative for the Treatment of Acute Liver Failure.肝实质细胞移植:急性肝衰竭治疗的一种治疗选择。
Can J Gastroenterol Hepatol. 2018 Jul 2;2018:2593745. doi: 10.1155/2018/2593745. eCollection 2018.
2
New Strategies for Acute Liver Failure: Focus on Xenotransplantation Therapy.急性肝衰竭的新策略:聚焦于异种移植治疗
Cell Med. 2010 Jul 1;1(1):47-54. doi: 10.3727/215517910X516646. eCollection 2010.
3
Microgravity as a means to incorporate HepG2 aggregates in polysaccharide-protein hybrid scaffold.
微重力作为将HepG2聚集体整合到多糖-蛋白质杂化支架中的一种手段。
J Mater Sci Mater Med. 2016 Feb;27(2):27. doi: 10.1007/s10856-015-5638-5. Epub 2015 Dec 24.
4
Bioreactor technologies to support liver function in vitro.支持体外肝功能的生物反应器技术。
Adv Drug Deliv Rev. 2014 Apr;69-70:132-57. doi: 10.1016/j.addr.2014.02.011. Epub 2014 Mar 5.
5
Effect of oxygen concentration on viability and metabolism in a fluidized-bed bioartificial liver using ³¹P and ¹³C NMR spectroscopy.采用 ³¹P 和 ¹³C NMR 光谱法研究氧浓度对流化床生物人工肝脏中细胞活力和代谢的影响。
Tissue Eng Part C Methods. 2013 Feb;19(2):93-100. doi: 10.1089/ten.TEC.2011.0629. Epub 2012 Sep 28.
6
Generating intestinal tissue from stem cells: potential for research and therapy.从干细胞生成肠道组织:研究和治疗的潜力。
Regen Med. 2011 Nov;6(6):743-55. doi: 10.2217/rme.11.90.
7
The effectiveness of a novel cartridge-based bioreactor design in supporting liver cells.一种新型基于盒式生物反应器设计在支持肝细胞方面的有效性。
Tissue Eng Part A. 2009 Oct;15(10):2903-16. doi: 10.1089/ten.TEA.2008.0279.
8
Artificial and bioartificial liver support: a review of perfusion treatment for hepatic failure patients.人工和生物人工肝支持:肝衰竭患者灌注治疗综述
World J Gastroenterol. 2007 Mar 14;13(10):1516-21. doi: 10.3748/wjg.v13.i10.1516.
9
Artificial liver support: future aspects.人工肝支持:未来展望。
J Artif Organs. 2005;8(2):71-6. doi: 10.1007/s10047-004-0286-4.
10
Development and perspectives of perfusion treatment for liver failure.肝衰竭灌注治疗的发展与展望
Surg Today. 2005;35(7):507-17. doi: 10.1007/s00595-004-2980-5.